Peer Support Intervention for Caregivers of Patients Undergoing HSCT
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital
About this trial
The main purpose of this study is to determine if a tailored peer support intervention (STEPP-Care) is feasible among caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult caregivers (≥18 years of age) of patients with hematologic malignancies who are undergoing autologous or allogeneic HSCT at Dana-Farber Cancer Institute.
Is a relative or friend who is identified by the patient to be their caregiver.
Ability to speak, read, and respond in English
Has access to a phone.
Disqualifiers
Caregivers with acute or unstable psychiatric conditions or other cognitive conditions that the treating oncologist believes would prohibit informed consent or ability to adhere to study procedures.
Trial design
Design model
Parallel
Treatments tested in this trial
STEPP-Care
BehavioralSTEPP-Care is a phone-delivered six-session structured peer support intervention for caregivers of patients undergoing hematopoietic stem cell transplantation.
Treatment groups
90 Participants
are divided into 2 treatment groupsGroup A: STEPP-CareExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Intervention Feasibility
Feasibility can be defined as \>/= 60% of STEPP-Care recipients completing 4/6 sessions
Time frame
up to 10 weeks2
Intervention Acceptability
Acceptability can be defined as average STEPP-Care intervention participant ratings \>20 on the Client Satisfaction Questionnaire
Time frame
up to 10 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: